Press Releases

Silo Wellness Eliminates Another CAD$4,440,000 of Debt from Balance Sheet by Disposing of Subsidiary Silo Wellness announces that the Company has entered into a definitive Stock Purchase Agreement dated March 27 2023 (the "Agreement") with a non-arm's length entity owned by Silo board member Michael Hartman ("Buyer") for the sale of Silo's wholly-owned subsidiary SW Holdings, Inc. ("SWHI") for a USD $150,000 purchase price paid out of any net proceeds from licensing or other revenue after any current lienholders are satisfied.

Silo Wellness Secures Right of First Refusal on All Psilocybin Mushroom Biomass from Medford, Oregon First-Mover Satya; Other Corporate Updates Silo Wellness announces that it is partnering with Oregon-based Satya, Inc. to develop a robust ecosystem aimed at supporting the well-being of psilocybin patients and Oregonian entrepreneurs alike.

Silo Wellness Public Float drops below 25% with New $41k Debt Conversion; Audit and FFCTO update Silo Wellness converted CAD$40,680.00 of accounts payable debt into common shares on Sunday, March 5, 2023, with the total debt converted year-to-date at over CAD$1 Million.

Silo Wellness Converts over $1 Million in Debt to Equity This Week with Another $119k Conversion Silo Wellness announced that it has reached an agreement with an arm's length creditor to convert CAD$118,650.00 of accounts payable debt for common shares at a conversion price of $0.011 per share for a total of 10,786,364 shares with the statutory four-month hold.

Silo Wellness Enters LOI with Largest Creditor Silo Wellnessannounced that it has entered into a Letter of Intent with Alpha Blue Ocean’s subsidiary Global Tech Opportunities 14 ...

Silo Wellness Oregon Psilocybin Update, Jamaica Retreat Article, Director Resignation Silo Wellness announced today that its Oregon attorneys have agreed to handle land use compatibility statements and overnight accommodation approval on a contingent fee agreement (“win fee”) for the psilocybin service center and cultivation project announced in January (refer to for risk factors).

Silo Wellness Announces Portland-area Rural Oregon Psilocybin Service Center and Cultivation Real Estate Partner Silo Wellness is pleased to announce that it has requested county approval for an Oregon psilocybin service center and psychedelic mushroom cultivation facility near the city of Portland.

Silo Wellness Announces Favorable Debt Restructure Terms Silo Wellness is pleased to announce that the Company and Global Tech Opportunities 14 ("Investor"), managed by Alpha Blue Ocean, have agreed to an amendment ...

Silo Wellness Wins Amendment to Proposed Land Use Ordinance for Oregon Psychedelic Ranch Silo Wellness an Oregon-based publicly traded psychedelics company, is pleased to announce that the Jackson County Planning Commission recommended to the elected commissioners the adoption of an amended land use ordinance that would allow Oregon psilocybin therapy service centers in a nature retreat setting in rural Jackson County.

Silo Wellness to Testify on Oregon Psilocybin Therapy Land Use Restrictions at Jackson County Planning Commission’s Thursday Hearing Silo Wellnessan Oregon-based publicly traded psychedelics company, announced that its Chief Executive Officer Mike Arnold, an Oregon lawyer, will testify Thursday, November 3, 2022, at the Jackson County Oregon Planning Commission’s 9:00 a.m. hearing regarding amendments to the Jackson County Land Development Ordinance to add psilocybin therapy and retreat time, place, and manner regulations.

Silo Wellness Announces Subsidiary’s Branding Licensing Agreement Terminated Oregon psychedelics company Silo Wellness announced that its wholly-owned subsidiary SW Holdings, Inc.’s (“SWHI”) License Agreement with Marley Green, LLC (“Licensor”) dated November 20, 2020, has been terminated as of October 24, 2022, by the licensor due to SWHI ’s failure to pay its guaranteed minimum royalties of USD$600,000 that were due and owing as of August 15, 2022, and for failure to obtain relevant insurance coverage minimums of USD$10 million.

Capitol Commitment

Silo Wellness Announces LOI For Retreat Center In Oregon Oregon psychedelics company Silo Wellness announces LOI for potentially largest psychedelic retreat center in Oregon and the world – if November’s election is favorable; and an Oregon Real Estate Law and Psilocybin Industry Analysis

Silo Wellness Closes Acquisition of Dyscovry Science and Its Psilocybin Pharmaceutical Biosynthesis and Research Portfolio Silo Wellness Inc, Oregon’s only publicly traded psychedelics company, is pleased to announce it has closed its acquisition of 100% of Dyscovry Science Ltd. (“Dyscovry”), a Toronto-based biotechnology company focused on biosynthetic manufacturing of psilocybin and its derivatives targeting a physiological condition, irritable bowel syndrome.

Silo Wellness Executes Definitive Agreement to Acquire Dyscovry Science and Its Psilocybin Pharmaceutical Biosynthesis and Research Portfolio Silo Wellness Inc, a leading global psychedelics company, and Dyscovry Science Ltd. (“Dyscovry”), a Toronto-based biotechnology company focused on biosynthetic manufacturing of psilocybin and its derivatives targeting a physiological condition, irritable bowel syndrome, today announced the companies have entered into a definitive share exchange agreement through which Silo acquires 100% of Dyscovry.

Silo Wellness Opens Jamaica Micro-Dosing Wellness Retreat Silo Wellness a leading global psychedelics company, is pleased to announce that it has opened its first ecotourism micro-dosing psilocybin resort and retreat center at Go Natural Jamaica in Long Bay, Portland, Jamaica.

Silo Wellness Organizes Jamaican Psilocybin Retreat Team and Advocates to Speak to Lane County (Eugene, Oregon) Commissioners Regarding BM109 Optout Vote; Lane County Declines to Refer a Psilocybin Ban to Voters The Silo Wellness Organizes Jamaican Psilocybin Retreat Team and Advocates to Speak to Lane County (Eugene, Oregon) Commissioners Regarding BM109 Optout Vote; Lane County Declines to Refer a Psilocybin Ban to Voters

Silo Wellness Issues Shareholder Letter and Announces New Chief Executive Officer Silo Wellness to Create a Psychedelic Pharmaceutical Manufacturing and Research Portfolio with Proposed Acquisition of Dyscovry Science "Silo Wellness announced today that Silo Wellness founder and chairman of the board of directors Mike Arnold is assuming the role of the Company’s interim chief executive officer to continue to lead the Company through its planned acquisition of Dyscovry Science Ltd. and in its planned Oregon psilocybin business objectives ..."

2022-05-31 - Silo Wellness to Create a Psychedelic Pharmaceutical Manufacturing and Research Portfolio with Proposed Acquisition of Dyscovry Science "Silo Wellness is pleased to announce that it has executed a nonbinding letter of intent to acquire 100% of Dyscovry Science Ltd., a Toronto-based biotechnology company. Dyscovry focuses on biosynthetic manufacturing of psilocybin and its derivatives targeting a physiological condition, irritable bowel syndrome. With Dyscovry's research collaboration with Canadian federal government research laboratories, Dyscovry intends to develop a biotechnological process for the production of psilocybin and its potentially novel molecule derivatives.."

2022-04-14 - Financing Commitment of CAD$5,950,000 in Convertible Debentures "As a publicly-traded psychedelics company offering psychedelics to guests in Jamaica and functional mushroom products across the U.S. and U.K., we welcome this transaction and the opportunity to work with Alpha Blue Ocean,” commented Douglas K. Gordon, Silo Wellness’s CEO. "This new capital will allow us to strengthen our balance sheet and focus on shareholder value creation through the expansion of our business model and, most directly, the growth of our Marley One line of functional mushroom products."

Capital Commitment

2022-02-23 - Successful Launch of 2022 Psilocybin Retreat Schedule and other Corporate Updates "I felt like a neural pathway in my brain had opened up. There was a release," stated Whitney Leming-Salisbury, a "Renew Your Purpose" retreat participant from the United States. "The combination of yoga, ceremonies, the workshops and one on one sessions with the guides, really solidified my integration with the medicine. Before you consider any other Earth medicine, I really think psilocybin is the best first step - especially with Silo, because the approach is gradual and gentle and there is no reason to fear at all - possibly the most beautiful approach I've ever had to a healing therapy."

2022-02-10 - Marley One Sponsors Metaverse Concert Series 'For the Love of Hip Hop' Virtual concert features Big Boi, Goodie Mob, Ying Yang Twins, Little Scrappy, Young Dro and more

2022-02-03 - USD$495,000 Strategic Equity Investment by Socially Conscious Metaverse and Psychedelics Holding Company Orthogonal Thinker Silo has entered into a subscription agreement (the “Subscription Agreement”) with respect to a strategic investment (the “Transaction”) with Orthogonal Thinker, Inc. (“Orthogonal Thinker”) an arm’s length third-party investor, pursuant to which the Company will issue 12,555,180 units of the Company (the “Units”) for aggregate gross proceeds to the Company of US$495,000. Each Unit will consist of one common share of the Company (“Common Share”) and one Common Share purchase warrant (each, a “Warrant”) exercisable for one Common Share at a price per Common Share of C$0.05 for a period of two years after the date of issue. UPDATE: The Alpha Blue Ocean financing announced on 4/14/2022 is in lieu of the previously announced transaction with Orthogonal Thinker which has been terminated.

Capital Committment

2022-01-06 - CEO Douglas K. Gordon Appointed to Board of Directors and Provides Corporation Updates Douglas K. Gordon, has been appointed as a director of the company. Mr. Gordon has led the company since 2020, through its pre-listing fundraising and into the public markets in March 2021, focusing on psychedelic retreats in Jamaica and the Marley One line of functional mushroom products. Mr. Gordon is the founder of CanEx Jamaica, the premier cannabis business conference and expo in the Caribbean. He has over 30 years of experience spanning finance, media, sales and marketing. Mr. Gordon has forged a vast global network with particular attention to developing business opportunities in the Caribbean and LATAM. Mr. Gordon has developed government and distribution relations in Jamaica as an experienced operator of a health and wellness distribution business and psychedelic retreats...

Board Appointment

2021-12-16 - Latest Psychedelic Retreat Offerings Company adds three new psilocybin-assisted retreats in Jamaica to accommodate increased demand for psychedelic tourism...

2021-12-08 - U.S. DTC Eligibility Douglas K. Gordon, Chief Executive Officer of Silo Wellness, said, “DTC eligibility is an important milestone in putting our story of ‘psychedelic healing now’ through Marley One mushroom products and wellness retreats in front of a broader audience of potential shareholders who share in our vision. This process speeds up the execution of trades and simplifies the transferring of shares between brokerages in the United States. DTC eligibility is also important for increasing our connections with the U.S. capital markets and increasing the liquidity of our stock..."

2021-10-12 - Marley One Line of Functional Mushrooms Now Sold On Amazon “Today, we’re celebrating an important milestone for Silo Wellness and for the mushroom industry at large,” said Douglas K Gordon, CEO, Silo Wellness. “From inception, our primary focus has been to broaden acceptance and support for the normalization of mushrooms and psychedelics and to make both available today, wherever possible, to help reduce trauma, enhance performance and create revenue in this burgeoning industry now. Our listing on Amazon, one of the largest ecommerce platforms in the world, takes us one step closer to that goal.”

2021-09-08 - Corporate Update: Filing of Subsidiary Interim Financial Statements Further to a continuous disclosure review by staff of the Ontario Securities Commission, the Company is filing the interim financial statements of FlyOverture Equity, Inc., a wholly-owned subsidiary of the Company, for the three month period ended January 31, 2021

2021-08-19 - $3 Million U.S. Sales and Distribution Partnership for Marley One Line of Functional Mushrooms “We have seen tremendous consumer interest in the Marley One brand, and we are pleased to announce a distribution partner for the all-important U.S. market,” said Douglas K. Gordon, Chief Executive Officer, Silo Wellness. “One Light is a respected and like-minded partner who shares our vision for Marley One and our commitment to delivering best-in-class consumer experiences and products.” One Light will distribute the full line of Marley One mushroom products, beginning with the brand’s initial five functional mushroom tinctures, to retailers across the U.S. Silo Wellness also intends to launch a psychedelic mushroom product line under the Marley name later this year, to be followed by additional functional mushroom products including gummies, capsules, and cosmetics. "We are excited to partner with Silo Wellness to bring Marley One to U.S. consumers,” said Twin Rivers Group, LLC, Managing Member of One Light. “We partner with some of the best-loved brands in the market today, and we anticipate Marley One will be well-received by consumers, particularly as they seek out natural, plant-based wellness products to enhance their everyday lives.”

2021-08-05 - Marley One Mushrooms to the U.K. Market through Distribution Agreement with LocoSoco Limited “Since the launch of Marley One, we’ve been vetting potential partners to help us bring the powerful health and wellness benefits of functional mushrooms to the U.K., where consumer interest in these products is on the rise, and psychedelic products as regulations allows,” said Douglas K. Gordon, Chief Executive Officer, Silo Wellness...

2021-07-13 - Trading on the OTCQB Under Symbol “SILFF” “Silo Wellness is pleased to be joining the OTCQB and improving access to our American shareholders. Our team is focused on building and accelerating the growth of the Marley One line of functional mushrooms, our Jamaican and Oregon wellness retreats, the cultivation of psychedelic mushrooms and truffles in Jamaica, the development of our brick-and-mortar smart shop in Jamaica and the commercialization of our metered-dosing psilocybin nasal spray,” said Douglas Gordon, Chief Executive Officer of Silo Wellness.

2021-06-24 - Silo Wellness Debuts Marley One, the First Global Functional and Psychedelic Mushroom Brand, in Collaboration with the Bob Marley Family “We know Bob would be proud of what we’re building with Silo Wellness and the Marley One brand,” said Rita Marley. “Our family has always revered the ancient history and transformative potential of nature’s gifts.”

2021-06-17 - Silo Wellness and Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Announces Psychedelics Genetic Test Kit Partnership The genetic test, a first of its kind, identifies specific DNA biomarkers in order to gauge the risk and potential of adverse reactions toward hallucinogenic drugs. The test provides users with personalized reports and actionable insights, delivered directly to one's smartphone, providing a convenient and safe means to better understand an individual's sensitivity to classical psychedelics and ketamine. The test also provides insights into the short- and long-term potential of psychedelic-induced risks, such as psychosis..

2021-06-02 - Silo Wellness Partners with Mushe Inc. to Establish First Legal Brick & Mortar Psychedelic and Functional Mushroom Shop in the Western Hemisphere “As a company, we are very bullish about the high-potential functional mushroom category and the psychedelics sector as a whole. We continue to invest in and expand our operations in Jamaica, the only country where the cultivation, extraction and sale of psilocybin mushrooms is permissible,” said Douglas K. Gordon, Chief Executive Officer of Silo Wellness. “Consumers are increasingly interested in incorporating mushrooms into their wellness routines. Through our propagation operations, psychedelic wellness retreats and upcoming retail location, it’s our aim to make mushroom-based products, experiences and education accessible at a time when so many people are struggling with mental health and other issues.”

2021-05-12 - Silo Wellness Partners with Kaivalya Kollectiv to Include 5-MeO-DMT In Psychedelic Portfolio Offering More commonly known by names like the “God molecule” or “The Toad,” 5-MeO-DMT is a research chemical psychedelic of the tryptamine class, four to six times more powerful than its better-known cousin, DMT (N,N-dimethyltryptamine). 5-MeODMT shows promise in the treatment of certain medical conditions, potentially improving general well-being and mindfulness as well as reducing the symptoms of psychological disorders with a single inhalation

2021-04-21 - Silo Wellness Announces Five New Psychedelic Wellness Retreats in Jamaica “We are prioritizing the expansion of our wellness retreat offerings to meet rising consumer demand for these transformative psychedelic experiences,” said Chief Executive Officer Douglas K. Gordon. “Setting and mindset have a profound influence on an individual’s experience, and our Jamaican retreats offer idyllic, natural backdrops for engaging in psilocybin-assisted exploration, introspection and self-actualization.”

2021-04-20 - Silo Wellness Appoints Phytomedicine Business Leader as Board Member Wayne Isaacs joins the board of Silo Wellness following nearly two decades serving in key leadership roles from President to Chief Executive Officer of several Toronto, Canada-based mineral exploration companies including Forsys Metals Corporation, Augustine Ventures, Inc. and Delta Uranium, Inc. As one of the first movers in the legalized Jamaican cannabis industry, Mr. Isaacs presently serves as CEO of Green Stripe Naturals, which was formed to take advantage of the tremendous worldwide opportunities in medicinal cannabis via vertically integrated business efforts on the island nation. Isaacs has business interests in natural medical-based solutions companies in Spain as well as co-owning a medical clinic in Ontario, Canada.

Board Appointment

2021-04-12 - Psychedelics Company Silo Wellness Expands its Shareholder Base to Europe by Commencing Trading on the German Börse Frankfurt (FRA) Exchange Under Ticker Symbol “3K70” “Expanding our shareholder base more broadly into the European market by commencing trading on the Frankfurt exchange is an important milestone for Silo Wellness as we continue to broaden our international presence,” said Douglas K. Gordon, Chief Executive Officer of Silo Wellness. “By listing on the FRA, a wider audience of investors will now be able to actively participate in the growth of Silo Wellness as we continue to deliver on our mission as well as grow on a global basis.”

Bloomberg article

Washington Post

Previous

Next

Silo Wellness

Take a look at all of Silo’s earned media from Forbes to Bloomberg to The Washington Post. Read about how Silo is advancing both psychedelic revenue and psychedelic healing right now.